Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 50 Carcinoma, Non-Small-Cell Lung 12 Neoplasms 11 Neoplasm Metastasis 10 Carcinoma, Renal Cell 7 Skin Neoplasms 5 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Lung Neoplasms 4 Glioblastoma 4 Diabetes Mellitus, Insulin-Dependent, 12 4 Carcinoma, Hepatocellular 4 Brain Neoplasms 4 Advanced Cancer 4 Uveal Melanoma 3 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Recurrence 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Breast Neoplasms 3 Waldenstrom Macroglobulinemia 2 Sarcoma 2 Myeloproliferative Disorders 2 Lymphoma, Mantle-Cell 2

Interventions

Cyclophosphamide 6 Isotretinoin 5 thymoglobulin 4 fludarabine phosphate 4 fludarabine 4 aldesleukin 4 Topotecan 4 Temozolomide 4 Melphalan 4 Irinotecan 4 Etoposide 4 ribociclib 3 Thiotepa 3 Interleukin-2 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Busulfan 3 Bone Marrow Transplantation 3 Antilymphocyte Serum 3 temsirolimus 2 omburtamab I-131 2 dinutuximab 2 Vincristine 2 Tretinoin 2 TPI-287 2 Stem Cell Transplantation 2 Rituximab 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neuroblastoma × Ipilimumab × Clear all

NCT04239040 2025-03-19

GVAX Plus Checkpoint Blockade in Neuroblastoma

Dana-Farber Cancer Institute

Phase 1 Terminated

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡